Arkrivis Technologies has announced that it was awarded by the National Cancer Institute (NCI) its second Phase I SBIR Contract.Read more
Quad Technologies Inc (“Quad”), developer of a novel cell separation technology, has secured a substantial amount of capital from its Series A round to accelerate development of disruptive cell processing technologies for translational medicine applications. The investment has enabled Quad to launch its MagCloudz™ Streptavidin Cell Separation Kit, which is the first commercially available productRead more
Microbeads: A Green Alternative -TerraVerdae BioWorks gears up for production using a proprietary process that successfully produces non-petroleum-based plastics that safely biodegrade.Read more
InsomniSolv, a NSIV Biotech member, presented its technology for the treatment of insomnia at the annual MA Medical Device Industry Council MedTech Showcase in Waltham, MA. Over 300 medtech investors and medical device business leaders gathered to hear from 23 startups. InsomniSolv was featured in the press release describing the event.Read more
Interested in incubating your company with NSIV? Submit your application today!